Interact CardioVasc Thorac Surg 2008;7:475-476. doi:10.1510/icvts.2007.174698A
© 2008 European Association of Cardio-Thoracic Surgery
ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery
Karsten Knobloch,
Andreas Gohritz,
Marcus Spies and
Peter M. Vogt
Plastic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover 30625, Germany
Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?
Regarding the omission of ACE inhibitors or angiotensin II receptor antagonists before cardiac surgery [1] one should consider the potential beneficial effect of ACE inhibitors as an antifibrotic agent. Postoperative atrial fibrillation (POAF) complicates up to 8% of all non-cardiac surgeries, between 3% and 30% of non-cardiac thoracic surgeries, and between 16% and 46% of cardiac surgeries. POAF has been associated with increased morbidity, mortality, and longer, more costly hospital stays [2].
Given the fact that atrial fibrillation is the most frequent complication following cardiac surgery, recent studies have been reported that ACE inhibitors and angiotensin II receptor blockers are emerging drugs for the prevention of atrial fibrillation by modification of the renin-angiotensinaldosterone system (RAAS) [3]. A meta-analysis of 11 randomized, controlled, parallel-design clinical trials evaluating effect of ACEIs or ARBs on the development of AF revealed that treatment with ACEIs or ARBs reduced the relative risk (RR) of AF in patients with hypertension by 23% and by 11% in patients after myocardial infarction. Reduction in AF was greatest in patients after electrical cardioversion and in patients with heart failure. Overall, inhibition of the RAAS reduced the RR of AF by 19% (RR 0.810, P<0.001, 95% CI 0.759–0.865). However, the effect of ACE inhibitors/angiotensin II receptor blockers on the postoperative rate of atrial fibrillation is undetermined as of yet.
The combination of a renin angiotensin system inhibitors (RAS-I) and bepridil might be even superior for the maintenance of sinus rhythm after conversion from persistent atrial fibrillation [4].
Based on these reports the omission of ACE inhibitors or angiotensin II receptor antagonists before cardiac surgery might have an effect on the postoperative rate of atrial fibrillation, which has to be determined in further perspective trials.
 |
References
|
|---|
- Raja SG, Fida N. Should angiotension converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilatation? Interact Cardiovasc Thorac Surg 2008;7:470–476.[Abstract/Free Full Text]
- Mayson SE, Greenspon AJ, Adams S, Decaro MV, Sheth M, Weitz HH, Whellan DJ. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy. Cardiol Rev 2007;15:231–241.[CrossRef][Medline]
- Jibrini MB, Molnar J, Arora RR. Prevetion of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis. Am J Ther 2008;15:36–43.[Medline]
- Kawamura M, Ito H, Onuki T, Miyoshi F, Minoura Y, Asano T, Tanno K, Kobayashi Y. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation. J Cardiol 2007;50:343–350.[Medline]
Related Article
-
Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?
- Shahzad G. Raja and Naveed Fida
Interactive CardioVascular and Thoracic Surgery 2008 7: 470-475.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
K. Knobloch
eComment: Postoperative atrial fibrillation following extrapleural pneumonectomy - which atrium is the driving force?
Interactive CardioVascular and Thoracic Surgery,
December 1, 2008;
7(6):
1043 - 1043.
[Full Text]
[PDF]
|
|
|
|
|
Top
References